These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7605161)

  • 1. Liposomal amphotericin B therapy in disseminated histoplasmosis.
    Harten P; Baron Y; Euler HH
    Arch Intern Med; 1995 Jul; 155(14):1556. PubMed ID: 7605161
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal amphotericin B therapy of murine histoplasmosis.
    Graybill JR; Bocanegra R
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1885-7. PubMed ID: 7486941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.
    Johnson PC; Wheat LJ; Cloud GA; Goldman M; Lancaster D; Bamberger DM; Powderly WG; Hafner R; Kauffman CA; Dismukes WE;
    Ann Intern Med; 2002 Jul; 137(2):105-9. PubMed ID: 12118965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.
    Poveda F; García-Alegría J; de las Nieves MA; Villar E; Montiel N; del Arco A
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):357-9. PubMed ID: 9721967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B in liposomes: a novel therapy for histoplasmosis.
    Taylor RL; Williams DM; Craven PC; Graybill JR; Drutz DJ; Magee WE
    Am Rev Respir Dis; 1982 May; 125(5):610-1. PubMed ID: 7081822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature.
    Johnson MD; Drew RH; Perfect JR
    Pharmacotherapy; 1998; 18(5):1053-61. PubMed ID: 9758315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.
    Cesaro S; Zignol M; Burlina AB; Tridello G; Visintin G; Messina C
    Pediatr Transplant; 2006 Mar; 10(2):255-8. PubMed ID: 16573618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infections.
    Ralph ED; Barber KR; Grant CW
    Scand J Infect Dis; 1993; 25(4):487-96. PubMed ID: 8248749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
    Ramu R; Sharma B; Karunakara D; Paliwal P; Bansal N; Taneja RS
    Indian J Pharmacol; 2021; 53(2):157-159. PubMed ID: 34100400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of liposomal amphotericin B in patients with high risk of nephrotoxicity].
    González E; Rada MA; Lumbreras C; Ramos JT; Aguado JM
    Enferm Infecc Microbiol Clin; 2000 Apr; 18(4):162-4. PubMed ID: 10932392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B-induced hypotension leading to ST segment elevated myocardial infarction.
    Golwala H; Patel N; Zacharias S; Lozano P
    Am J Ther; 2011 Sep; 18(5):e157-8. PubMed ID: 21734533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive disseminated histoplasmosis as seen in adults.
    Md State Med J; 1971 Feb; 20(2):77-8. PubMed ID: 5141511
    [No Abstract]   [Full Text] [Related]  

  • 15. Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency.
    Pasic S; Flannagan L; Cant AJ
    Bone Marrow Transplant; 1997 Jun; 19(12):1229-32. PubMed ID: 9208117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amphotericin B in the therapy of acute pulmonary histoplasmosis].
    Bochkarev MV
    Antibiotiki; 1971 Nov; 16(11):1045-8. PubMed ID: 5147753
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus.
    Späth-Schwalbe E; Koschuth A; Dietzmann A; Schanz J; Possinger K
    Clin Infect Dis; 1999 Mar; 28(3):680-1. PubMed ID: 10194097
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
    J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections].
    Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Monchecourt F; Mahi L; Deray G
    Med Mal Infect; 2008 Apr; 38(4):208-14. PubMed ID: 18191521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine.
    Zhang X; Jin J; Cai C; Zheng R; Wang Y; Xu Y
    Indian J Pharmacol; 2016; 48(3):321-3. PubMed ID: 27298506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.